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Abstract
Research that classifies breast tumors into homogenous sub-
groups could ultimately help to define public health prevention
strategies for aggressive breast cancer subtypes. However,
etiologic research on molecular breast cancer subtypes must
overcome several challenges. Stratifying breast cancers into
subgroups can reduce statistical power and, therefore, may require
non-traditional analytical methods. Integrating results across
studies is hampered by varying definitions of molecular subtypes,
with some studies using triple negative status and others using
specific markers to define basal-like cancers. In addition, triple
negative and basal-like breast cancers appear to show strong
associations with race, so the varied racial and ethnic composition
of different datasets can make comparison across studies
challenging. In spite of these challenges, some strong and con-
sistent associations between triple negative or basal-like breast
cancer and demographic variables are emerging, and there are
hints that prevention strategies for this aggressive subtype of
breast cancer may also be attainable.
Growing evidence supports the concept of breast cancer as
a group of diseases with distinct etiologies. In a recent issue
of Breast Cancer Research, Kwan and colleagues [1] report
a pooled analysis of molecular subtypes in two prospective
breast tumor datasets. Their analysis of 2,544 invasive breast
cancers is a well-powered, case-only analysis of associations
between established breast cancer risk factors and molecular
subtypes of breast cancer [2,3]. Together with similar
findings from other studies, the results suggest racial
disparities in the etiology of breast cancer subtypes and
indicate that prevention strategies may be possible for
aggressive breast cancers.
Evidence suggesting that distinct molecular subtypes of
breast cancer have different etiologies has developed primarily
from case-control studies. Case-control studies compare risk
factor distributions among breast cancer cases to distributions
among controls. In case-control analyses, breast cancer cases
can be taken as a whole or can be stratified by molecular
subtype [4-7], but as the cases are divided into subgroups,
the power to discover associations can be reduced. To
address this challenge, a few studies have used an alternative
study design, the case-only design, to study breast cancer
subtypes [1,4,8-10]. Instead of defining controls as the
referent group, case-only analyses compare risk factor
distributions or pathology characteristics across subtypes (for
example, comparing HER2-enriched, basal-like, or luminal B
tumors to luminal A tumors). In case-only analyses, risk factor
distributions that differ significantly across subgroups of cases
are interpreted as etiologic heterogeneity. Case-only studies
have a history of use for investigating gene-environment
interactions and can be an efficient and powerful approach
[11,12]. Thus, by pooled analysis of two studies and an
efficient case-only design, Kwan and colleagues [1] have
replicated previous significant findings and report novel
interactions in the etiology of breast cancer subtypes.
Several previously reported interactions between risk factors
and breast cancer subtypes are confirmed in the report by
Kwan and colleagues [1]. Their work supports interactions
between parity and breastfeeding in triple negative breast
cancer (TNBC) and/or basal-like breast cancer (BBC) [4,5].
Collectively, the data suggest that breastfeeding may be
particularly important for preventing aggressive subtypes of
breast cancer. The analyses by Kwan and colleagues [1] also
support previously reported links between TNBC/BBC and
obesity [4,6]. However, there have been divergent results for
different obesity measures within and across studies and in
interaction with other exposures [4,6,9,10]. While associa-
tions between obesity and molecular subtypes remain un-
certain, there is agreement across several studies regarding
patterns of breast cancer incidence by age and race.
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Many of the studies linking race and aggressive breast
cancer subtypes have included a substantial percentage of
African Americans, allowing strong inference about subtype
and racial disparities. The pooled analysis of the Life After
Cancer Epidemiology (LACE) and Pathways studies included
just 6% African-American cases [1], but a significant
association was still observed between TNBC and race. In
fact, the association between African American race and
TNBC was among the strongest associations observed in
their study. While evidence for a shift toward more aggressive
subtypes in African-American women is consistent across
several studies and has been observed in Surveillance,
Epidemiology, and End Results (SEER) data [13], uncertainty
remains about the genetic and environmental factors that
contribute to the associations between race and breast
cancer subtype. Complex relationships between biology,
socioeconomics, and race exist, and future research in
racially diverse populations will be needed to disentangle
these factors and address disparities in breast cancer.
In integrating findings across studies, perhaps the greatest
challenge is a lack of agreement about molecular definitions
for subtypes. TNBCs include not only tumors that are truly
BBCs, but also tumors for which there were false negatives
for one or more of the three markers (estrogen receptor,
progesterone receptor, or HER2). BBCs are measured with
specificity by adding positive markers such as cytokeratin 5/6
or epidermal growth factor receptor [14] and future studies
may take advantage of a 50-gene quantitative PCR assay for
molecular subtypes [15]. Nonetheless, specific markers for
BBC are not presently available in most studies and the
resulting misclassification can be substantial. In the Carolina
Breast Cancer Study and the Polish Women’s Health Study,
only 60% and 66%, respectively, of TNBCs were BBCs
when specific, positive markers were included in the
definition of that subtype. Distinguishing true BBC from
TNBC has had important implications for clinical prognosis
[14], and while it has been argued that these distinctions may
be more important in clinical than etiologic research [6],
misclassification can be an important bias and deserves
careful consideration. Kwan and colleagues [1] have
emphasized the importance of these molecular definitions
and propose future research on their dataset using specific
BBC markers.
Research on the epidemiology of molecular subtypes is
challenging. Ideal studies include biomarker data that allow
classification of breast cancers into homogeneous
subgroups, have large and racially diverse samples, and
utilize efficient analytic strategies. This analysis by Kwan and
colleagues [1] has contributed important data confirming that
different breast cancer subtypes have unique profiles by
reproductive factors, age, and race. This study and others like
it hold the promise of defining novel prevention strategies for
breast cancer subtypes that contribute to racial disparities.
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